We and others have identified VP as a causal candidate of metabolic and cardiovascular disease [25, 26], and human and animal experiments have shown beneficial metabolic effects from water‐induced VP and copeptin reduction [10, 17]. Here, AVP is linked to cardiovascular disorder.